Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Inspire Medical Systems Inc. (INSP)

  • Business News
  • Dec. 22, 2025, 09:32 UTC
  • 14
  • 1 comments

INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Inspire Medical Systems Inc. (INSP)

  • Business News
  • Dec. 22, 2025, 09:00 UTC
  • 12
  • 1 comments

January 5, 2026 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INSP

Market reaction Comment Full text

Perrigo Company plc (PRGO)

  • Business News
  • Dec. 22, 2025, 09:00 UTC
  • 10
  • 1 comments

Perrigo Company plc Sued for Securities Law Violations - Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - PRGO

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Dec. 22, 2025, 09:00 UTC
  • 10
  • 1 comments

The Gross Law Firm Reminds Integer Holdings Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 9, 2026 - ITGR

Market reaction Comment Full text

DexCom Inc (DXCM)

  • Business News
  • Dec. 22, 2025, 09:00 UTC
  • 9
  • 1 comments

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - DXCM

Market reaction Comment Full text

Incyte Corporation (INCY)

  • Business News
  • Dec. 22, 2025, 07:44 UTC
  • 13
  • 1 comments

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma

Market reaction Comment Full text

Incyte Corporation (INCY)

  • Business News
  • Dec. 22, 2025, 07:42 UTC
  • 17
  • 1 comments

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer

Market reaction Comment Full text

AstraZeneca (AZN)

  • Business News
  • Dec. 22, 2025, 07:35 UTC
  • 14
  • 1 comments

Enhertu granted BTD for post-neoadjuvant early BC

Market reaction Comment Full text

AstraZeneca (AZN)

  • Business News
  • Dec. 22, 2025, 07:02 UTC
  • 16
  • 1 comments

Update on LATIFY Phase III trial of ceralasertib

Market reaction Comment Full text

Alvotech (ALVOW)

  • Business News
  • Dec. 22, 2025, 07:00 UTC
  • 15
  • 1 comments

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

Market reaction Comment Full text
  • Previous
  • 255
  • 256
  • 257
  • 258
  • 259
  • Next

Search

News categories

  • Technical Exchange News(10896)
  • Event(2288)
  • SEC News(189980)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124724)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin